Oritavancin on the Results of Multiple Coagulation Tests in Healthy Volunteers
Status:
Completed
Trial end date:
2015-03-01
Target enrollment:
Participant gender:
Summary
The study will determine the magnitude and duration (time to resolution i.e., returning to
normal ranges) of elevations in the following coagulation test results after a single 1200 mg
dose of oritavancin: Prothrombin Time/International Normalized Ratio (PT/INR), Activated
clotting time (ACT), Activated Partial Thromboplastin Time (APTT), Chromogenic Factor Xa
Assay, D-dimer, Silica Clot Time and Dilute Russell's Viper Venom Time (DRVVT).